News | April 20, 2026
Eli Lilly flags counterfeit Mounjaro seizure in Gurugram
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The EMBOLD study evaluated relutrigine for patients with SCN2A and SCN8A developmental and epileptic encephalopathies
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
TSC causes epilepsy in up to 85 % of patients, and up to 60 % of those patients do not respond to standard anti-seizure medicines
New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
This is an exciting and meaningful milestone for GRIN Therapeutics
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The approval comes after a systematic review of published literature
Subscribe To Our Newsletter & Stay Updated
